Emerging markets represent the most significant long-term growth opportunity in global IVD. Asia-Pacific is projected to register the highest CAGR during the forecast period, fueled by rapidly increasing healthcare expenditure in China, India, and Southeast Asia. China's import substitution policy is creating competitive pressure for international suppliers while enabling enormous growth in domestic Chinese IVD companies such as Mindray, AUTOBIO, and Shengxiang. India's Make in India initiative is attracting IVD manufacturing investment. GCC states are channeling oil revenues into laboratory infrastructure under Vision 2030. Sub-Saharan Africa benefits from donor-funded HIV, tuberculosis, and malaria diagnostic programs. Latin American laboratories face currency fluctuations and import tariffs, driving local sourcing. In South Korea, Turkey, and Brazil, emerging domestic suppliers are building export capabilities and forming co-production partnerships with global leaders.
Topics Covered
• Emerging Markets IVD Market Size and Forecast 2025-2030 by Region and Country
• Asia-Pacific IVD — China, India, Japan, South Korea, and Southeast Asia
• China IVD — Domestic Supplier Growth, Import Substitution, and Market Share Dynamics
• India IVD — Healthcare Infrastructure Investment and Market Development
• Middle East IVD — GCC Vision 2030, Laboratory Infrastructure, and Supplier Positioning
• Latin America IVD — Brazil, Mexico, Argentina, and Regional Market Dynamics
• Africa IVD — Donor-Funded Programs, HIV/TB/Malaria Testing, and Infrastructure
• Domestic vs. International Supplier Competitive Dynamics by Region
• Investment and Partnership Opportunities
Table of Contents
1. Executive Summary
2. Market Overview
3. Emerging Markets IVD Market Size and Forecast 2025-2030 by Region and Country
4. Asia-Pacific IVD
5. China IVD
6. India IVD
7. Middle East IVD
8. Latin America IVD
9. Africa IVD
10. Domestic vs. International Supplier Competitive Dynamics by Region
11. Competitive Landscape
12. Regional Market Analysis
13. Strategic Conclusions and Recommendations
14. Appendix
List of Tables
Table 1. China IVD Market — Domestic vs. Multinational Supplier Competitive Dynamics 2025
Table 2. India IVD Market — Segment Analysis and Key Suppliers 2025
Table 3. Southeast Asia IVD Markets — Country Analysis 2025
Table 4. Middle East and GCC IVD Markets — Investment Programs and Key Suppliers 2025
Table 5. Latin America IVD Markets — Country Analysis and Regulatory Framework 2025
Table 6. Africa IVD Markets — Donor-Funded Programs and Commercial Market 2025
Table 7. Emerging Markets IVD — Regulatory Framework by Country 2025
Table 8. Leading Domestic Suppliers in Emerging Markets — Mindray, AUTOBIO, and Others 2025
Table 9. M&A and Partnership Activity in Emerging Markets 2023-2025
Table 10. Key Risks and Mitigation Strategies
Companies Profiled
Abbott Laboratories
Becton Dickinson
Bio-Rad Laboratories
bioMérieux
DiaSorin
Hologic
Qiagen
Roche Diagnostics
Siemens Healthineers
Sysmex
